Su Hui therapy
About:
HealiRNA is a ribonucleic acid drug research and development company.
Website: https://www.healrna.com/
Top Investors: HongShan, Shunwei Capital, Sino-Singapore Capital, Ming Bioventures, Yajie Shanghui
Description:
HealiRNA develops infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They provide mRNA drug research and development, production, clinical trial design, and data analysis services.
Total Funding Amount:
100M CNY
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2021-05-18
Contact Email:
HR(AT)healrna.com
Founders:
Number of Employees:
101-250
Last Funding Date:
2023-03-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai